The University of Texas System Cancer Genter 
M. D. Anderson Hospital and Tumor Institute 
Texas Medical Center • 6723 Bertner Avenue • Houston, Texas 77030 
January 25, 1983 
William J. Gartland, Jr., Ph.D. 
Office of Recombinant DNA Activities 
Room 4A52 
Bethesda, Maryland 20205 
Dear Dr. Gartland: 
The Recombinant DNA Subcommittee of our Institutional 
Biosafety Committee has reviewed the Revised Guidelines for 
Research Involving Recombinant DNA Molecules published in the 
Federal Register on August 27, 1982. The subcommittee has 
found no inherent or operational problems in the revised 
guidelines as written. Our IBC is a general biosafety 
committee that meets once each month and has found no diffi- 
culty in reviewing and processing the recommendations of the 
Recombinant DNA Subcommittee for research involving recom- 
binant molecules under these revised guidelines. 
Robert C . Hickey , M . D . 
Executive Vice President 
The University of Texas 
RCH : j a j 
[ 586 ] 
